Article Information
- Received January 4, 2016
- Revision received June 30, 2016
- Accepted July 26, 2016
- First published September 14, 2016.
- Version of record published September 14, 2016.
Author Information
- Charleine Zussy1,2,*,
- Fabien Loustalot1,2,*,
- Felix Junyent1,2,*,
- Fabrizio Gardoni3,
- Cyril Bories4,
- Jorge Valero10,
- Michel G. Desarménien2,5,
- Florence Bernex6,
- Daniel Henaff1,2,
- Neus Bayo-Puxan1,2,
- Jin-Wen Chen7,
- Nicolas Lonjon8,
- Yves de Koninck4,
- João O. Malva10,
- Jeffrey M. Bergelson7,
- Monica di Luca3,
- Giampietro Schiavo9,
- Sara Salinas1,2, and
- Eric J. Kremer1,2
- 1Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France,
- 2Université de Montpellier, 34000 Montpellier, France,
- 3Università degli Studi di Milano, Department of Pharmacological Sciences and Centre of Excellence on Neurodegenerative Diseases, 20122 Milan, Italy,
- 4Mental Health Institute of Quebec and Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University, Quebec City, G1V 0A6 Quebec, Canada,
- 5Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique, Inserm, 34394 Montpellier, France,
- 6Institut Régional du Cancer Montpellier, Inserm, 34090 Montpellier, France,
- 7Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104,
- 8Département de Neurochirurgie, Hôpital Gui de Chauliac, 34000 Montpellier, France,
- 9Sobell Department of Motor Neuroscience and Movement Disorders, University College London Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom, and
- 10Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal
Author contributions
Author contributions: C.Z., F.J., M.G.D., J.M.B., G.S., S.S., and E.J.K. designed research; C.Z., F.L., F.J., F.G., C.B., J.V., F.B., D.H., N.B.-P., J.-W.C., N.L., and S.S. performed research; Y.d.K., J.O.M., J.M.B., and M.D.L. contributed unpublished reagents/analytic tools; C.Z., F.L., F.J., F.G., C.B., M.G.D., F.B., J.O.M., J.M.B., M.D.L., G.S., S.S., and E.J.K. analyzed data; C.Z., S.S., and E.J.K. wrote the paper.
↵*C.Z., F.L., and F.J. contributed equally to this work.
Disclosures
- Received January 4, 2016.
- Revision received June 30, 2016.
- Accepted July 26, 2016.
Work in the Kremer laboratory was funded by the EC European Commission FP7 (BrainCAV #226992, BrainVectors ##286071), the L'Agence Nationale de la Recherche ANR, E-Rare, the La Fondation de France, and L'Association de Recherche pour la Sclérose Latérale Amyotrophique. E.J.K. and S.S. are Inserm fellows. We thank the staff of the IGMM animal facilities MRI for help with microscopy studies; T. Gostan for help with statistical analyses; S. Musardo and S. Pelucchi for technical help; F. Tronche for the nestin-Cre mice; T. Maurice for help with the behavioral studies; R. G. Kelly for help with LPS injections; and J. Zabner and K. Excoffin for anti-CAR antibodies.
- Correspondence should be addressed to either of the following: Sara Salinas, INSERM ADR Languedoc-Roussillion, 60 Rue de Navacelles, Montpellier 34394, France. sara.salinas{at}inserm.fr; or Eric J. Kremer at the above address, eric.kremer{at}igmm.cnrs.fr
Online Impact
Article usage
In this issue
